Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biologics manufacturing
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
PharmNXT Biotech unveils maiden integrated manufacturing unit for single-use bioprocessing systems
The state-of-the-art facility has been launched to address the challenges of biologics manufacturing in the country